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Abstract
BACKGROUND/AIM: In rat pancreatic islets, beta-cell gene expression, survival
and subsequent acute glucose stimulation of insulin secretion (GSIS) are
optimally preserved by prolonged culture at 10 mM glucose (G10) and markedly
altered by culture at G5 or G30. Here we tested whether pharmacological
glucokinase (GK) activation prevents these alterations during culture or improves
GSIS after culture. METHODS: Rat pancreatic islets were cultured 1-7 days at
G5, G10 or G30 with or without 3 µM of the GK activator Ro 28-0450 (Ro). After
culture, beta-cell apoptosis and islet gene mRNA levels were measured, and
the acute glucose-induced increase in NAD(P)H autofluorescence, intracellular
calcium concentration and insulin secretion were tested in the absence or
presence of Ro 28-0450. RESULTS: Prolonged culture of rat islets at G5 or
G30 instead of G10 triggered beta-cell apoptosis and reduced their glucose
responsiveness. Addition of Ro during culture differently affected beta-cell
surviv...
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Abstract 28 
Background/aim: In rat pancreatic islets, 29 
beta-cell gene expression, survival and 30 
subsequent acute glucose stimulation of 31 
insulin secretion (GSIS) are optimally 32 
preserved by prolonged culture at 10 mM 33 
glucose (G10) and markedly altered by 34 
culture at G5 or G30. Here we tested 35 
whether pharmacological glucokinase (GK) 36 
activation prevents these alterations during 37 
culture or improves GSIS after culture. 38 
 39 
Methods: Rat pancreatic islets were 40 
cultured 1-7 days at G5, G10 or G30 with 41 
or without 3 µM of the GK activator Ro 28-42 
0450 (Ro). After culture, beta-cell apoptosis 43 
and islet gene mRNA levels were 44 
measured, and the acute glucose-induced 45 
increase in NAD(P)H autofluorescence, 46 
intracellular calcium concentration and 47 
insulin secretion were tested in the absence 48 
or presence of Ro 28-0450. 49 
 50 
Results: Prolonged culture of rat islets at 51 
G5 or G30 instead of G10 triggered beta-52 
cell apoptosis and reduced their glucose 53 
responsiveness. Addition of Ro during 54 
culture differently affected beta-cell 55 
survival and glucose responsiveness 56 
depending on the glucose concentration 57 
during culture: it was beneficial to beta-cell 58 
survival and function at G5, detrimental at 59 
G10, and ineffective at G30. In contrast, 60 
acute GK activation with Ro increased the 61 
glucose sensitivity of islets cultured at G10, 62 
but failed at restoring beta-cell glucose 63 
responsiveness after culture at G5 or G30. 64 
 65 
Conclusions: Pharmacological GK 66 
activation prevents the alteration of beta-67 
cell survival and function by long-term 68 
culture at G5, but mimics glucotoxicity 69 
when added to G10. The complex effects of 70 
glucose on the beta-cell phenotype result 71 
from changes in glucose metabolism and 72 
not from an effect of glucose per se. 73 
74 
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Introduction 75 
The glucose stimulation of insulin secretion 76 
(GSIS) by endocrine pancreatic beta-cells 77 
depends on the acceleration of glucose 78 
metabolism through glycolysis and the 79 
Krebs cycle, with enhanced production of 80 
metabolic coupling factors (25; 39; 41). 81 
Besides these rapid effects, glucose exerts 82 
complex long-term effects on the β-cell 83 
phenotype (2; 10; 16; 18; 27; 45). During 84 
long-term culture of rodent islets, beta-cell 85 
gene expression, survival and glucose 86 
responsiveness are optimally preserved in 87 
the presence of 10 mM glucose (G10), 88 
whereas they are markedly altered by 89 
culture at either non-stimulating (G5) or 90 
very high (G30) glucose concentrations. In 91 
other words, culture at G10 vs. G5 is 92 
beneficial, whereas culture at G30 vs. G10 93 
is detrimental to beta-cell gene expression, 94 
survival and glucose responsiveness. The 95 
beneficial effect of culture at G10 vs. G5 is 96 
usually attributed to the stimulation of 97 
energetic metabolism. In contrast, the 98 
deleterious effects of culture at G30 vs. 99 
G10, which we later refer to as 100 
glucotoxicity, could result from the further 101 
increase in metabolism with increased 102 
production of reactive oxygen species 103 
(ROS) and endoplasmic reticulum stress, or 104 
from various mechanisms that do not 105 
exclusively depend on glucose metabolism, 106 
e.g. through increased glycation of 107 
extracellular proteins, activation of the 108 
receptor for advanced glycation-end 109 
products (RAGE), or a hypothetical 110 
osmotic effect of high glucose 111 
concentrations (1). 112 
Glucokinase (GK) is a high Km hexokinase 113 
expressed in hepatocytes, pancreatic beta-114 
cells and a few other cell types involved in 115 
glucose homeostasis (29; 30). In beta-cells, 116 
GK is the glucose sensor that controls the 117 
rate of glycolysis, hence insulin secretion, 118 
within the physiological range of glucose 119 
concentrations (28). Given the pivotal role 120 
of GK in glucose homeostasis, small 121 
molecule GK activators (GKAs) were 122 
developed that augment GSIS and hepatic 123 
glucose utilization (17), thereby improving 124 
glucose homeostasis in rodent and human 125 
type 2 diabetes (T2D) (3; 7; 11; 13; 29; 31; 126 
33; 48). However, although some GKAs 127 
may improve beta-cell survival and GSIS 128 
under glucotoxic conditions, the loss of 129 
GKA effectiveness during long-term 130 
treatment of T2D (22; 47) raises questions 131 
about their possible toxicity, e.g. through 132 
sustained beta-cell stimulation. 133 
In this study, we tested the ability of the 134 
GKA Ro 28-0450 (Ro) to prevent or correct 135 
the alterations of the beta-cell phenotype by 136 
prolonged culture at G5 or G30 vs. G10. 137 
We also indirectly tested whether the 138 
complex effects of glucose on the beta-cell 139 
phenotype in cultured rat islets result from 140 
changes in glucose metabolism or from an 141 
effect of glucose per se. 142 
 143 
Materials and Methods 144 
Materials – Diazoxide and dithiothreitol 145 
(DTT) were from Sigma (St-Louis, MI, 146 
USA), the glucokinase activator (GKA) Ro 147 
28-0450 (3-Cyclopentyl-2-(4-148 
methansulfonyl-phenyl)-N-thiazol-2-yl-149 
propionamide) was from Axon Medchem 150 
(Groningen, The Netherlands), and the 151 
GKA Compound A (2-Amino-5-(4-methyl-152 
4H-(1,2,4)-triazole-3-yl-sulfanyl)-N-(4-153 
methyl-thiazole-2-yl)benzamide) was from 154 
Calbiochem (Merck, Darmstadt, Germany). 155 
Islet isolation and culture – Male Wistar rat 156 
islets were isolated by collagenase digestion 157 
of the pancreas, purified by gradient 158 
centrifugation using Histopaque 1077, and 159 
hand-picked under a stereomicroscope. 160 
They were precultured at 37°C and 5% CO2 161 
in serum-free RPMI 1640 medium 162 
(Invitrogen, Carlsbad, CA, USA) 163 
containing 100 U/ml penicillin, 100 µg/ml 164 
streptomycin, 5 g/L BSA and 10 mM 165 
glucose (G10). They were then cultured  for 166 
up to 1 week in the same medium 167 
containing G5, G10 or G30 and 3 or 30 µM 168 
Ro or vehicle alone (dimethylsulfoxide 169 
1/1000). The islets were transferred to fresh 170 
medium every other day. All experiments 171 
were approved by the local ethics 172 
committee for animal experimentation 173 
(project 2013/UCL/MD/016). 174 
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Gene mRNA levels - Islet total RNA 175 
extraction and reverse transcription were 176 
carried out as described (19), except for the 177 
use of Tripure (Roche Diagnostics GmbH, 178 
Mannheim, Germany), RevertAidTM 179 
Reverse Transcriptase and RibolockTM 180 
RNase inhibitor (Thermo Scientific). Real-181 
time PCR were performed with a CFX96 182 
(Bio-Rad) using primers and reaction 183 
conditions as in (2; 10). 184 
Cell apoptosis - Histone-associated DNA 185 
fragments were measured in islet cell 186 
cytosolic extracts using the Cell Death 187 
Detection ELISAPLUS kit (Roche 188 
Diagnostics), exactly as described in (36). 189 
The percentage of apoptotic beta-cells was 190 
determined on islet sections by TUNEL 191 
using the “In Situ Cell Death Detection Kit” 192 
(Roche Diagnostics) followed by insulin 193 
immunostaining (9). 194 
Mitochondrial GSH/GSSG redox status - 195 
The mitochondrial redox status was 196 
assessed by measuring the thiol/disulfide 197 
equilibrium with the “redox sensitive Green 198 
Fluorescent Protein” targeted to the 199 
mitochondria (mt-roGFP1) (14), as 200 
described (9; 40). The mt-roGFP1 201 
fluorescence ratio was normalized to the 202 
difference between the ratio measured after 203 
addition of 10 mM dithiothreitol (set to 0%) 204 
and that measured after addition of 1 mM 205 
H2O2 (set to 100%). 206 
Total glutathione content - Total 207 
glutathione was measured with the 208 
DetectX® Glutathione Fluorescent 209 
Detection Kit (Arbor Assays, Ann Arbor, 210 
MI, USA) and normalized for differences in 211 
islet protein content (9; 40). 212 
Intracellular Ca2+ concentration ([Ca2+]i) - 213 
After culture, islets were loaded for 2 h 214 
with fura2-LR-acetoxymethylester (Teflabs, 215 
Austin, TX) in a medium similar to that 216 
used during culture. Islets were then 217 
perifused (flow rate ~1 ml/min) with a 218 
bicarbonate-buffered Krebs solution 219 
containing (mM) NaCl (120), KCl (4.8), 220 
CaCl2 (2.5), MgCl2 (1.2), NaHCO3 (24), 1 221 
g/l BSA, glucose (0.5 to 20), and various 222 
test substances. When the concentration of 223 
KCl was raised to 30 mM, that of NaCl was 224 
reduced to 94.8 mM to keep the osmolarity 225 
unchanged. The acute glucose-induced 226 
changes in [Ca2+]i were recorded by 227 
microspectrofluorimetry as described (21). 228 
NAD(P)H autofluorescence - After culture, 229 
islets NAD(P)H autofluorescence was 230 
recorded by microspectrofluorimetry in 231 
perifused islets as described (21). The data 232 
were normalized to the fluorescence level 233 
measured 20 min after addition of 10 µM 234 
FCCP to G20. 235 
Insulin secretion during culture – After 236 
culture, the medium was centrifuged 5 min 237 
at 500 rpm (20 x g) and the supernatant was 238 
appropriately diluted for determination of 239 
insulin concentration by RIA using rat 240 
insulin as a standard (16). 241 
Acute insulin secretion – After culture, 242 
islets were preincubated for 45 min in a 243 
bicarbonate-buffered Krebs solution 244 
containing G0.5, then incubated in batches 245 
of 5 for 1 h at various glucose 246 
concentrations. At the end, the medium was 247 
collected for insulin measurement and the 248 
islet insulin and DNA contents were 249 
measured on each batch of islets (23). 250 
Insulin secretion was normalized for 251 
variations in islet DNA content. 252 
Statistical analysis - Results are means ± 253 
SE for at least 3 preparations. Statistical 254 
significance of differences between groups 255 
was assessed by 2-way ANOVA followed 256 
by a test of Bonferroni, unless specified 257 
otherwise. Except in figure 1, these 258 
statistical analyses were done separately for 259 
the groups G5/G5+Ro/G10 and for the 260 
groups G10/G30 +/- Ro. Differences were 261 
considered significant at P<0.05. 262 
 263 
Results 264 
Effects of Ro 28-0450 on the glucose 265 
regulation of gene mRNA expression and 266 
beta-cell apoptosis in cultured rat islets - 267 
We first tested the effects of two 268 
chemically-unrelated GKAs, Ro 28-0450 269 
(Ro) and Compound A, during overnight 270 
culture at increasing glucose 271 
concentrations, on insulin secretion, on the 272 
islet mRNA levels of metallothionein 1a 273 
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(Mt1a), a sensitive indicator of oxidative 274 
stress in rat islets (18), and on the mRNA 275 
levels of thioredoxin-interacting protein 276 
(Txnip), a sensitive marker of beta-cell 277 
glucotoxicity (5). The strong regulation of 278 
these genes and of insulin secretion over 279 
different parts of the glucose concentration-280 
response curve (2) should provide an 281 
optimal system to compare the intensity of 282 
the effects of GKAs and glucose in rat 283 
islets. 284 
As expected (2), glucose markedly 285 
increased insulin secretion in the culture 286 
medium between G5 and G30, increased 287 
Txnip mRNA expression between G10 and 288 
G30, and reduced islet Mt1a mRNA levels 289 
between G2 and G10 (Fig. 1). Under these 290 
conditions, Ro concentration-dependently 291 
shifted to the left the three glucose-response 292 
curves without significantly affecting the 293 
maximal responses at G30 (Fig. 1A-C). At 294 
30 µM, close to its maximal effective 295 
concentration in vitro (13), addition of Ro 296 
to G2 tended to reproduce the effects of 297 
G10 alone, and its addition to G5 was 298 
almost as effective as G30 alone. At 3 µM, 299 
close to its semi-maximal effective 300 
concentration, addition of Ro to G2 was 301 
almost ineffective, its addition to G5 302 
mimicked the effects of G10 alone, and its 303 
addition to G10 largely reproduced the 304 
effects of G30 alone. The latter 305 
concentration of Ro seemed optimal to test 306 
whether the complex effects of glucose on 307 
the beta-cell phenotype result from the 308 
stimulation of glucose metabolism, and we 309 
therefore used it in subsequent protocols. 310 
The GKA compound A also shifted to the 311 
left the glucose-response curves for changes 312 
in insulin secretion and Txnip mRNA 313 
expression (Fig. 1D and E). However, 314 
compound A induced a ~20-fold increase in 315 
Mt1a mRNA levels at G10 (Fig. 1F), 316 
suggesting a possible rapid toxic effect of 317 
the drug. We therefore stopped testing that 318 
compound. 319 
We next tested the effect of 3 µM Ro on 320 
insulin secretion, islet gene expression and 321 
beta-cell survival during one-week of 322 
culture at G5, G10 or G30. The effects of 323 
glucose on insulin secretion during culture 324 
and on Txnip and Mt1a to Tbp mRNA 325 
ratios were similar to those observed after 326 
overnight culture (Fig. 2A-C). Compared 327 
with prolonged culture at G10 that 328 
optimally preserved rat beta-cell function 329 
and survival, there were a large decrease in 330 
preproinsulin (Ppi) to Tbp mRNA ratio, 331 
increase in islet DNA fragmentation and 332 
increase in beta-cell apoptosis after culture 333 
at G5 (Fig. 2D-F), consistent with the toxic 334 
effect of prolonged culture at G5 vs. G10 on 335 
beta-cell gene expression and survival. On 336 
the other hand, there was a small non-337 
significant decrease in Ppi to Tbp mRNA 338 
ratio and a significant ~2-fold increase in 339 
the percentage of apoptotic beta-cells after 340 
culture at G30 (Fig. 2D and F), confirming 341 
the glucotoxic effect of culture at G30 vs. 342 
G10 on beta-cell gene expression and 343 
survival. 344 
As shown in figure 2A-F, addition of Ro to 345 
G5 during one-week culture largely 346 
reproduced the effects of culture at G10 347 
alone on all parameters tested, while 348 
addition of Ro to G10 reproduced the 349 
effects of culture at G30 alone. However, 350 
Ro had no significant effect on insulin 351 
secretion, islet gene expression or beta-cell 352 
apoptosis during culture at G30. These 353 
results are easily explained if one considers 354 
that i) the long-term effects of culture at 355 
G10 vs. G5 result from an increase in 356 
glucose metabolism that can be achieved by 357 
adding 3 µM Ro to G5, and ii) the long-358 
term effects of culture at G30 vs. G10 result 359 
from an increase in glucose metabolism that 360 
can be achieved by adding 3 µM Ro to 361 
G10. 362 
We have previously shown that the 363 
glucose-induced changes in rat beta-cell 364 
apoptosis are preceded by parallel changes 365 
in the oxidation of mitochondrial redox-366 
sensitive Green Fluorescent Protein (mt-367 
roGFP1) (9; 40), a good indicator of 368 
mitochondrial thiol oxidation (32). Similar 369 
changes in mt-roGFP1 fluorescence ratio 370 
were observed in the present study, with a 371 
large increase after culture at G5 vs. G10, 372 
and a small significant increase after culture 373 
at G30 vs. G10 (Fig. 3A). An increase in 374 
islet glutathione content was also observed 375 
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at G5 vs. G10 (Fig. 3B). Again, addition of 376 
Ro to G5 prevented the increase in mt-377 
roGFP1 fluorescence ratio and islet 378 
glutathione content induced by culture at 379 
G5 alone (Fig. 3), in parallel with later 380 
changes in beta-cell apoptosis (Fig. 2E-F). 381 
However, addition of Ro to G10 did not 382 
affect mt-roGFP1 fluorescence ratio as did 383 
culture at G30 alone (Fig. 3A), in contrast 384 
with the effect of the drug on beta-cell 385 
apoptosis (Fig. 2F). 386 
Effects of one week culture at G5, G10 and 387 
G30 on islet glucose responsiveness (the 388 
data described hereafter correspond to 389 
dotted traces and open symbols in all 390 
panels from figure 4) - Prolonged culture at 391 
a non-stimulating or very high vs. 392 
intermediate glucose concentration not only 393 
triggers beta-cell apoptosis but also reduces 394 
the islet insulin content and induces marked 395 
alterations of the beta-cell secretory 396 
responses to subsequent acute glucose 397 
simulation (9; 21; 40). In agreement with 398 
previous studies, after one week culture at 399 
G10 alone, rat islets displayed typical 400 
changes in NAD(P)H autofluorescence, 401 
[Ca2+]i and insulin secretion upon acute 402 
stepwise glucose stimulation: a 403 
concentration-dependent increase in 404 
NAD(P)H autofluorescence (Fig. 4B), a 405 
transient decrease in [Ca2+]i without 406 
significant effect on insulin secretion at G6 407 
and a concentration-dependent increase in 408 
[Ca2+]i upon stimulation with G10 and G20 409 
(Fig. 4E), and a concentration-dependent 410 
stimulation of insulin secretion above G5 411 
(Fig. 4H). As expected, both [Ca2+]i and 412 
insulin secretion were further stimulated by 413 
high K+-induced depolarization in the 414 
presence of diazoxide (K30Dz)(Fig. 4E and 415 
H). 416 
After one week culture at G5 alone, the islet 417 
insulin to DNA content ratio (see legend to 418 
fig. 4G-I) and the acute glucose-induced 419 
rise in NAD(P)H autofluorescence were 420 
reduced by ~60-70%, while the glucose 421 
induced rise in [Ca2+]i and stimulation of 422 
insulin secretion were almost fully 423 
abrogated (Fig. 4A, D, G). In these islets, 424 
the secretory response to K30Dz was also 425 
suppressed despite the presence of a normal 426 
[Ca2+]i rise. In contrast, after one week 427 
culture at G30 alone, a condition known to 428 
induce rat beta cell glucotoxicity, the islet 429 
insulin to DNA content ratio was reduced 430 
by ~30% (see legend to figure 4), the basal 431 
levels of NAD(P)H autofluorescence and 432 
[Ca2+]i in G0.5 were increased, and the rises 433 
in NAD(P)H autofluorescence, [Ca2+]i and 434 
insulin secretion were of much lower 435 
amplitude or absent (Fig. 4C, F, I). 436 
However, the responses to K30Dz were 437 
unaffected, except for a reduction in insulin 438 
secretion that was proportional to the 439 
reduction in islet insulin content. 440 
Effects of long-term GK activation during 441 
culture at G5, G10 and G30 on subsequent 442 
islet glucose responsiveness - Addition of 443 
Ro during one week culture markedly 444 
affected the islet insulin to DNA content 445 
ratio (see legend to figure 4) and 446 
subsequent functional responses to acute 447 
glucose and K30Dz stimulation (Fig. 4, 448 
thick continuous traces vs. dotted traces, 449 
and closed vs. open symbols). Thus, the 450 
insulin to DNA content ratio and functional 451 
responses of islets cultured at G5 with Ro 452 
were similar to those recorded in islets 453 
cultured at G10 alone, except for the higher 454 
glucose sensitivity of the former (Fig. 4: 455 
compare thick traces or closed symbols in 456 
panels A, D, G with dotted traces or open 457 
symbols in panels B, E, H). Also, the 458 
functional responses of islets cultured at 459 
G10 with Ro were similar to those recorded 460 
in islets cultured at G30 alone (Fig. 4: 461 
compare thick traces or closed symbols in 462 
panels B, E, H with dotted traces or open 463 
symbols in panels C, F, I). Finally, addition 464 
of Ro during culture at G30 did not 465 
significantly affect the islet insulin to DNA 466 
content ratio or the rise in [Ca2+]i and 467 
insulin secretion upon acute stimulation 468 
with glucose and K30Dz (Fig. 4F, I), 469 
although their NAD(P)H autofluorescence 470 
increased significantly less upon glucose 471 
stimulation than in islets cultured at G30 472 
alone (Fig. 4C). 473 
Effects of acute GK activation after culture 474 
at G5, G10 and G30 on subsequent islet 475 
glucose responsiveness – Our previous 476 
protocol tested the effect of Ro addition 477 
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during culture on subsequent islet glucose 478 
responsiveness in the absence of the drug. 479 
We next tested the acute effects of Ro 480 
addition after culture on beta-cell glucose 481 
responsiveness during perifusion or 1 h 482 
incubations. As shown in figure 5, addition 483 
of Ro after one week culture at G10 alone 484 
shifted to the left the acute glucose-485 
response curves for changes in NAD(P)H, 486 
[Ca2+]i and insulin secretion without 487 
affecting their maximal responses to G20 488 
(Fig. 5B, E, H, thick continuous vs. dotted 489 
traces, closed vs. open symbols). Addition 490 
of Ro during perifusion also shifted to the 491 
left the glucose-induced changes in 492 
NAD(P)H after 3 days of culture at G5 493 
alone (Fig. 5A) but not after culture at G30 494 
alone (Fig. 5C). However, it did not 495 
significantly restore the amplitude of the 496 
[Ca2+]i and insulin secretion responses upon 497 
acute glucose stimulation, neither in islets 498 
cultured at G5 (Fig. 5D,G) nor in islets 499 
cultured at G30 (Fig. 5F,I). It also did not 500 
improve the lack of effect of K30Dz 501 
stimulation on insulin secretion in islets 502 
cultured at G5 (Fig. 5G, closed vs. open 503 
squares). 504 
 505 
Discussion 506 
In rodent pancreatic islets cultured for 1-3 507 
weeks at various glucose concentrations, 508 
beta-cell gene expression, survival and 509 
function are optimally preserved at G10 and 510 
markedly altered at G5 and at G30, the 511 
latter condition triggering beta-cell 512 
glucotoxicity (reviewed in (1; 18; 27)). In 513 
this study, acute pharmacological GK 514 
activation increased the glucose sensitivity 515 
of control islets but failed at restoring beta-516 
cell glucose-responsiveness in rat islets 517 
cultured for one week at non-stimulating or 518 
very high vs. intermediate glucose 519 
concentration. In contrast, chronic GK 520 
activation prevented the alteration of beta-521 
cell survival and function by prolonged 522 
culture at non-stimulating glucose, was 523 
detrimental during culture at G10, and was 524 
almost ineffective at G30. 525 
Impact of GK activation in rat islets 526 
cultured at a non-stimulating glucose 527 
concentration – As expected (9; 16; 26), 528 
long-term culture of rodent islets at G5 529 
markedly reduced Ppi mRNA levels and 530 
beta-cell glucose responsiveness while 531 
increasing beta-cell apoptosis and markers 532 
of oxidative stress (mt-roGFP1 oxidation 533 
and Mt1a mRNA levels (Fig. 2 and 3). The 534 
blunted GSIS could be due to reduced GK 535 
expression (24) and adoption of its “wide-536 
open” conformation with low activity and 537 
resistance to GKA effect (15; 20). Thus, 538 
although Ro 28-0450 significantly 539 
increased the glucose sensitivity of islets 540 
cultured at G10 (Fig. 5B,E,H), it could not 541 
increase the glucose-induced rise in [Ca2+]i 542 
nor GSIS after culture at G5 (Fig. 5D,G). 543 
However, this lack of effect was not due to 544 
a lack of efficacy on glucose metabolism, 545 
for Ro significantly shifted to the left the 546 
glucose-induced rise in NAD(P)H 547 
autofluorescence even if it did not increase 548 
its low amplitude (Fig. 5A). Together with 549 
our previous observation that the 550 
antioxidant drug MnTBAP partially 551 
restored the glucose-induced rise in [Ca2+]i 552 
without increasing the amplitude of the rise 553 
in NAD(P)H autofluorescence or GSIS 554 
(40), and with the observation that K30-555 
induced insulin secretion was abrogated 556 
despite the preservation of K30-induced 557 
rise in [Ca2+]i, our results suggest that the 558 
defect in GSIS after culture at non-559 
stimulating glucose does not only result 560 
from the reduction in glucose metabolism 561 
but also from defective coupling between 562 
the rise in [Ca2+]i and exocytosis (9; 40). 563 
In contrast with its poor efficacy in the 564 
acute setting, moderate GK activation 565 
during long-term culture fully prevented all 566 
deleterious effects of G5 vs. G10 on beta-567 
cell gene expression, survival and function. 568 
These results, which are in good agreement 569 
with an earlier study on the effect of GKA 570 
on the islet transcriptome after culture at G5 571 
(12), confirm that the deleterious effects of 572 
prolonged culture at non-stimulating 573 
glucose mainly result from the sustained 574 
decrease in glucose metabolism (26; 42). 575 
GK activation and beta-cell glucotoxicity – 576 
As expected, prolonged culture of rat islets 577 
at G30 vs. G10 tended to reduce Ppi mRNA 578 
levels, increased beta-cell apoptosis and 579 
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markers of oxidative stress (Fig. 2 and 3), 580 
and induced typical alterations of beta-cell 581 
stimulus-secretion coupling events 582 
culminating in a strong reduction of GSIS 583 
with only slight reduction in K30Dz-584 
induced secretion (Fig. 4C,F,I and 5C,F,I). 585 
Despite its efficacy in islets cultured at 586 
G10, Ro did not acutely increase the 587 
average glucose-induced rise in [Ca2+]i nor 588 
GSIS after culture at G30. Such lack of 589 
effect contrasts with recent reports showing 590 
that two GKAs (GKA50 and YH-GKA) 591 
that are chemically different from Ro 592 
acutely reversed the glucotoxic alterations 593 
of beta-cell function (35; 46). Although we 594 
only tested the effect of Ro in this protocol, 595 
other GKAs were found ineffective under 596 
similar conditions, indicating that the effect 597 
of GKA50 and YH-GKA unlikely resulted 598 
from GK activation (46). 599 
When Ro was added during culture at G10, 600 
it triggered all glucotoxic alterations of 601 
beta-cell gene expression, survival and 602 
function recorded after culture at G30 603 
alone, except for the lack of increase in mt-604 
roGFP1 fluorescence ratio. The latter effect 605 
aside, these results therefore unequivocally 606 
exclude the role of an effect of glucose per 607 
se in beta-cell glucotoxicity, in agreement 608 
with earlier studies in which mice with one-609 
allele GK inactivation did not develop beta-610 
cell glucotoxicity despite stable 611 
hyperglycemia (38; 43). These results do 612 
not tell us, however, whether these 613 
alterations are due to the activation of 614 
glucose oxidation, glycogen synthesis, or 615 
the pentose phosphate pathway. 616 
The intriguing dissociation between the 617 
proapoptotic effect of Ro and its lack of 618 
effect on mt-roGFP1 fluorescence ratio at 619 
G10 suggests that beta-cell apoptosis 620 
induced by Ro and maybe G30 is 621 
independent of mitochondrial thiol 622 
oxidation. It also sheds light on the 623 
mechanism of ROS production during 624 
culture at high glucose, suggesting this 625 
event is independent of glucose metabolism 626 
and acceleration of mitochondrial electron 627 
transport chain and might therefore involve 628 
other pathways, e.g. AGE’s formation and 629 
activation of RAGE (1). 630 
Implications for the treatment of T2D 631 
patients with GKAs - If GKAs undoubtedly 632 
trigger liver steatosis (4; 6; 34), their 633 
potential toxicity to beta-cells remains 634 
unclear (4; 35; 38; 43; 44; 46). Thus, 635 
although some GKAs proved beneficial to 636 
beta-cell survival and GSIS under 637 
glucotoxic conditions and in islets from 638 
T2D patients (8; 35; 46), their secondary 639 
failure during long-term treatment (22; 31; 640 
47) reopened the question of their toxicity 641 
to beta-cells. This possible caveats of 642 
GKAs has been previously considered non-643 
relevant on the ground that beta-cell 644 
stimulation is reduced following the GKA-645 
mediated reduction in glycemia (12). 646 
However, given the metabolic 647 
heterogeneity of beta-cells in rodent islets 648 
(37), the present study suggests that GKAs 649 
may be beneficial in poorly-responsive 650 
beta-cells while being simultaneously toxic 651 
to middle- and highly-responsive beta-cells 652 
through a variety of mechanisms proposed 653 
to contribute to glucotoxicity (1). If such 654 
“glucotoxic-like” effect of long-term GKAs 655 
treatment at intermediate glucose 656 
concentration were confirmed in human 657 
islets, it could contribute to the secondary 658 
failure of GKAs in T2D (22; 31; 47). 659 
In conclusion, the GKA Ro 28-0450 660 
prevents the toxic effect of long-term 661 
culture at non-stimulating glucose while 662 
mimicking the glucotoxic alterations of the 663 
beta-cell phenotype when added during 664 
culture at G10. These results prove that in 665 
vitro beta-cell glucotoxicity fully depends 666 
on the stimulation of glucose metabolism 667 
and not on an effect of high glucose per se. 668 
They also provide a plausible explanation 669 
for the lack of long-term efficacy of GKAs 670 
in T2D. 671 
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Legends to the figures 1057 
Figure 1. Overnight effects of glucose and two GKAs on insulin secretion, Txnip and Mt1a 1058 
mRNA levels in cultured rat islets - After one week preculture in serum-free RPMI medium 1059 
containing 10 mM glucose (G10) and 5 g/l BSA, islets were cultured 18 h at G2, G5, G10 or G30 1060 
with 3 µM GKA (closed circles), 30 µM GKA (open squares) or DMSO 1/1000 (open circles). The 1061 
GKA was Ro 28-0450 (A-C) or compound A (D-F). A, D, insulin secreted during culture. B-C, E-1062 
F, islet Txnip and Mt1a to Tbp mRNA ratios normalized to the ratio in G10-cultured islets. Data are 1063 
means ± SE for 3-4 experiments. *, P<0.05 for the effect of glucose vs. G2; #, P<0.05 for the effect 1064 
of GKA vs. DMSO. 1065 
 1066 
Figure 2. Long-term effects of glucose and Ro on insulin secretion during culture, islet gene 1067 
mRNA levels and beta-cell apoptosis - After overnight preculture in serum-free RPMI medium 1068 
12 
 
containing G10 and 5 g/l BSA, rat islets were cultured one week at G5, G10 or G30 with 3 µM Ro 1069 
(closed circles) or vehicle alone (open circles). A, average rate of insulin secretion over one week of 1070 
culture (measured every two days). B-D, islet Txnip, Mt1a and preproinsulin (Ppi) to Tbp mRNA 1071 
ratios normalized to the ratio in G10-cultured islets. E, cytosolic histone-associated 1072 
oligonucleosomes. F, percentage of apoptotic beta-cells (TUNEL-positive / DAPI-positive nuclei in 1073 
insulin-positive cells). Results are means ± SE for 3 experiments (panels A-E) or for 5-7 1074 
experiments with 6933-8378 counted cells from 44-71 islets (panel F). *, P<0.05 for the effect of 1075 
culture at G5 or G30 vs. culture at G10; #, P<0.05 for the effect of Ro during culture at the same 1076 
glucose concentration. §, P<0.05 for the effect of Ro by Student’s t-test. F, due to the non-Gaussian 1077 
distribution of the data, the statistical significance of differences between groups was assessed by a 1078 
test of Kruskal-Wallis with a Dunn’s multiple comparisons post-test. 1079 
 1080 
Figure 3. Effects of glucose and Ro on mt-roGFP1 fluorescence ratio and total glutathione - A, 1081 
rat islet cell clusters expressing mt-roGFP1 were cultured overnight at G5, G10 or G30 with 3 µM 1082 
Ro (closed circles) or vehicle alone (open circles). The mt-roGFP1 fluorescence ratio was measured 1083 
and normalized as described under “Methods”. B, after one week preculture, islets were cultured 18 1084 
h at G5, G10 or G30 with Ro (closed circles) or vehicle alone (open circles). Their total glutathione 1085 
content was measured and normalized to their protein content. Results are means ± SE for 3 1086 
experiments (for a total of 12-25 islet cell clusters in panel A). *, P<0.05 for the effect of culture at 1087 
G5 or G30 vs. culture at G10; #, P<0.05 for the effect of Ro during culture at the same glucose 1088 
concentration. 1089 
 1090 
Figure 4. Long-term effects of Ro addition during culture at G5, G10 or G30 on subsequent 1091 
acute glucose stimulus-secretion coupling events in rat islets – The islets were cultured for 1 1092 
week at G5 (A, D, G), G10 (B, E, H) or G30 (C, F, I) in the presence of 3 µM Ro (thick traces, 1093 
closed symbols) or vehicle alone (thin dotted traces, open symbols). They were then perifused or 1094 
incubated for 1 h at increasing glucose concentrations (Gn) in the absence of Ro. A-C, acute 1095 
glucose-induced changes in NAD(P)H autofluorescence, expressed as percentage of the 1096 
fluorescence measured at the end of 10 µM FCCP application. D-I, acute glucose-induced changes 1097 
in [Ca2+]i. The experiments ended by depolarization with 30 mM extracellular K+ in the presence of 1098 
G20 and 250 μM diazoxide (G20K30Dz). G-I, acute glucose stimulation of insulin secretion in 1099 
normal Krebs solution (circles) or in the presence of K30Dz (squares). The results were normalized 1100 
for differences in islet DNA content. The insulin to DNA content ratios (ng insulin per ng DNA, 1101 
mean ± SE, n=4) were 0.092 ± 0.008 and 0.273 ± 0.004 in islets cultured at G5 with DMSO or with 1102 
Ro, 0.245 ± 0.011 and 0.173 ± 0.016 in islets cultured at G10 with DMSO or with Ro, and 0.157 ± 1103 
0.004 and 0.164 ± 0.007 in islets cultured at G30 with DMSO or with Ro. Results are means ± SE 1104 
for 7-14 islets from 2-3 isolations (A-C), 20-38 islets from 3-4 experiments (D-F) or 4 experiments 1105 
(G-I). The statistical significance of differences between groups were computed using the increase 1106 
in NAD(P)H autofluorescence, [Ca2+]i or insulin secretion above the level measured in G0.5 or 1107 
before depolarization with K30. * P<0.05 for the effect of culture at G5 or G30 vs. culture at G10; 1108 
#, P<0.05 for the effect of Ro addition during culture at the same glucose concentration. The 1109 
significance of the acute glucose effect in each group is not shown. 1110 
 1111 
 1112 
 1113 
Figure 5. Acute effects of Ro on glucose stimulus-secretion coupling events in rat islets after 1114 
one week culture at G5, G10 or G30 – The islets were cultured for a total of 1 week in a medium 1115 
containing G10 then G5 during the last 3 days (A, D, G), G10 (B, E, H), or G30 (C, F, I). They 1116 
13 
 
were then perifused or incubated for 1 h at increasing glucose concentrations (Gn) in the absence 1117 
(thin dotted traces, open symbols) or presence of 3 µM Ro (thick traces, closed symbols). A-F, 1118 
acute glucose-induced changes in NAD(P)H autofluorescence and [Ca2+]i (see legend to figure 4). 1119 
G-I, acute glucose stimulation of insulin secretion in normal Krebs solution (circles) or in the 1120 
presence of K30Dz (squares). The insulin to DNA content ratios (ng insulin per ng DNA, mean ± 1121 
SE, n=4) were 0.191 ± 0.011 and 0.181 ± 0.003 in islets cultured at G5 and incubated 1 h without or 1122 
with Ro, 0.353 ± 0.014 and 0.367 ± 0.021 in islets cultured at G10 and incubated 1 h without or 1123 
with Ro, and 0.241 ± 0.016 and 0.287 ± 0.007 in islets cultured at G30 and incubated without or 1124 
with Ro. Shown are means ± SE for 18–33 islets from 3-4 isolations (A-C), 22–41 islets from 3-4 1125 
experiments (D-F), or 4 experiments (G-I). The statistical significance of differences between 1126 
groups were computed as in Fig. 4. * P<0.05 for the effect of culture at G5 or G30 vs. culture at 1127 
G10; #, P<0.05 for the effect of Ro addition during the perifusion or incubation in islets cultured at 1128 
the same glucose concentration. The significance of the acute glucose effect in each group is not 1129 
shown. 1130 
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